Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

61.32
-0.2333-0.38%
Volume:865
Turnover:53.06K
Market Cap:9.20M
PE:- -
High:61.36
Open:61.36
Low:61.32
Close:61.55
52wk High:64.69
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:6.41
T/O Rate:0.58%
Dividend:0.51
Dividend Rate:0.83%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

OverviewCompanyNewsFilings

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS
·
Sep 10

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Dr. Oz Hails 'Historic Weight Loss' Due to GLP-1s

Dow Jones
·
Sep 10

Bank of America Reveals 5.22% Indirect Stake in Qiagen

TIPRANKS
·
Sep 10

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
Sep 10

Sector Update: Healthcare

MT Newswires Live
·
Sep 10

Why Is UnitedHealth Stock (UNH) Down on Wednesday, 9/9/2026?

TIPRANKS
·
Sep 10

Casey's Says GLP-1s Aren't to Blame for Slow Snack Sales

Dow Jones
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Sep 09

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call

THOMSON REUTERS
·
Sep 09

Abbvie Exec Says Expects Approval of Subcutaneous Crohn's Disease Treatment in Q4 - Conf Call

THOMSON REUTERS
·
Sep 09
More